Axl inhibition on dendritic cells enhances STING anticancer therapy through type I interferon signaling

Imagine your body is a bustling city under constant threat from a sneaky criminal gang: cancer. To keep the city safe, you have a highly trained police force called the immune system. Among these officers are the "Dendritic Cells," who act as the intelligence officers. Their job is to find evidence of the criminals (tumor cells), grab a piece of them, and rush to the central station to show the "CD8+ T Cells"—the elite SWAT team—what the enemy looks like. Once the SWAT team sees the evidence, they multiply and hunt down the cancer cells with extreme prejudice.

However, the criminals are clever. They often try to bribe or confuse the police to stop them from sounding the alarm. One way they do this is by triggering a specific "brake" on the intelligence officers. This brake is a protein called Axl. Think of Axl as a "Do Not Disturb" sign that the cancer cells force onto the police officers' desks. When this sign is up, the officers stop shouting for backup, the SWAT team never gets the call, and the cancer grows unchecked. Scientists have long known that Axl helps cancer cells survive, but they weren't sure exactly how it stopped the police from doing their job. This study dives into the police station to find out which specific officer is being silenced and how we can remove that "Do Not Disturb" sign to win the war.

---

The Detective Work: Finding the Silent Officer

The researchers started by asking a simple question: What happens if we completely remove the Axl protein from the body's immune system? They used mice that were genetically engineered to lack Axl and injected them with three different types of cancer cells (colorectal, melanoma, and breast cancer). The result was immediate and dramatic: the tumors grew much slower in the mice without Axl compared to normal mice.

But which part of the immune system was responsible for this victory? Was it the macrophages (the street sweepers), the NK cells (the patrol units), or the dendritic cells (the intelligence officers)? To solve this, the scientists created special mice where Axl was removed only from specific cell types. They found that removing Axl from macrophages did nothing to stop the cancer. However, when they removed Axl specifically from the dendritic cells, the tumors slowed down just as much as in the mice with no Axl at all.

This was a huge clue. It meant that the "Do Not Disturb" sign was most dangerous when it was stuck on the intelligence officers' desks. Specifically, the study pinpointed a sub-type of dendritic cell called cDC1 as the key player. These are the officers responsible for cross-presenting antigens—essentially, the ones who show the SWAT team the most accurate "Wanted" posters.

The Mechanism: How the Brake Works

So, how does Axl actually stop the cDC1 officers? The study revealed a fascinating chain of events. When a dendritic cell eats a dying cancer cell, it usually triggers a loud alarm called Type I Interferon. This alarm is the signal that wakes up the CD8+ T cells (the SWAT team) and tells them to multiply and attack.

The researchers discovered that Axl acts as a silencer for this alarm. When a dendritic cell eats a tumor cell, Axl kicks in and suppresses the Type I Interferon signal. It's like the officer eats the evidence but then immediately turns off the siren before calling for backup. Without that siren, the SWAT team stays asleep, and the cancer wins.

In the mice without Axl, this silencer was gone. When the cDC1 cells ate the cancer cells, the Type I Interferon alarm blared at full volume. This led to a massive surge in CD8+ T cell activation. The study showed that these T cells were much better at recognizing and killing the tumor. In fact, when the researchers blocked the Type I Interferon signal in the Axl-free mice, the cancer started growing fast again, proving that the "Interferon Alarm" was the secret weapon.

The "Efferocytosis" Twist: Eating the Evidence

One of the most interesting parts of the study involves how these cells eat. The process of eating dead cells is called efferocytosis. You might think that eating more dead cells would make the officers more alert. However, the study found something counterintuitive: the Axl-free cDC1 cells actually ate fewer dead cancer cells than the normal cells.

Despite eating less, they were more effective at activating the T cells. Why? Because without the Axl brake, every single cell they did eat triggered a much stronger Type I Interferon response. It's like a detective who only needs to find one tiny clue to solve a massive case, whereas the normal detective needs a mountain of clues but gets distracted and forgets to call for help. The Axl-free cells were more efficient at turning what they ate into a powerful immune signal.

The Big Idea: A New Combo Strategy

The most exciting part of the paper is the proposed solution. Scientists have been trying to use drugs called STING agonists to treat cancer. These drugs work by artificially triggering that same Type I Interferon alarm, hoping to wake up the immune system. However, in many patients, these drugs don't work well because the cancer cells have installed the Axl "Do Not Disturb" sign, which immediately shuts the alarm down.

The researchers tested a new strategy: what if we use a drug to block Axl at the same time we use the STING agonist? They treated mice with a drug called Bemcentinib (which blocks Axl) and a STING agonist called DMXAA.

The results were impressive.

• In mice with tumors that usually resist treatment, using the STING agonist alone did very little.
• Using the Axl blocker alone helped a bit.
• But using both together caused the tumors to shrink dramatically and significantly extended the lives of the mice.

This combination worked even in mice where the cancer cells themselves didn't have Axl, proving that the benefit came from removing the brake on the immune system's dendritic cells, not from attacking the cancer cells directly.

What This Means for the Future

This paper suggests that Axl is a critical "intrinsic checkpoint" for dendritic cells. It's a built-in safety mechanism that the body uses to prevent over-reaction, but cancer hijacks it to stay hidden. By blocking Axl, we can remove this safety mechanism specifically for the immune cells, allowing them to respond much more fiercely to cancer.

The study explicitly rules out the idea that macrophages are the main target for this therapy; the effect is driven almost entirely by cDC1 dendritic cells. It also confirms that this process relies heavily on CD8+ T cells; when the researchers removed these T cells from the Axl-free mice, the tumors grew fast again, showing that the T cells are the final executioners.

While this research was done in mice, it provides a strong blueprint for human treatment. It suggests that for patients with cancers that are resistant to current immunotherapies, adding an Axl inhibitor to the mix could be the key to unlocking the immune system's full potential. It turns a "Do Not Disturb" sign into a "Call for Backup" siren, giving the body's own police force the clear signal they need to take down the criminal gang.